nuclear medicine supply chain production

Framatome Announces New Investment Supporting Nuclear Medicine

Framatome Announces New Investment Supporting Nuclear Medicine Framatome (ENS Corporate Member) announced that it acquired a minority stake in the French startup Global Morpho Pharma. With this investment, Framatome strengthens its activities serving nuclear medicine development and expands its support for the supply chain of Lutetium-177 and other promising isotopes for therapeutic applications. Global Morpho…

nuclear medicine cooperation

The New PSI Pharmaceutical Laboratory Is Ready For Production

The New PSI Pharmaceutical Laboratory Is Ready For Production Paul Scherrer Institut (PSI, ENS Corporate Member) announced that its new pharmaceutical laboratory for the manufacture of radiopharmaceuticals is ready for production, accordingly to the operating licence granted by the Swiss Agency for Therapeutic Products (Swissmedic). For more than 20 years, in collaboration with ETH Zurich,…

EnCore ATF

Westinghouse And EDF To Cooperate On EnCore® ATF Technology

Westinghouse And EDF To Cooperate On EnCore® ATF Technology Westinghouse Electric Company announced a partnership with EDF (both ENS Corporate Members) to explore the functionalities of Westinghouse’s EnCore® enhanced Accident Tolerant Fuel (ATF) technology. Westinghouse will study its EnCore fuel in an EDF reactor for potential deployment across the EDF nuclear fleet after 2030. This…